|
|
Welcome to the COVID-19 Vaccine Partner Newsletter! Here you'll find the latest news and information on COVID-19 vaccine related topics.
|
|
Q: WHAT TYPES OF PROOF OF COVID-19 VACCINATION ARE ACCEPTED IN WASHINGTON STATE?
A: There are several types of proof that are accepted in Washington state.
- CDC COVID-19 Vaccination card
- Originals, copies or photographs on a mobile device are acceptable
-
WA State Immunization Information System (WAIIS) printout
- Certification of Immunization Status (CIS) forms printed from the WAIIS
- Hand-written entries are not valid unless signed by a medical provider
- Certificate of COVID-19 vaccination from MyIRmobile.com
-
WAverify.org SMART Health Card or QR code
- QR code displayed on an endorsed partner mobile app
- Verified electronic medical record printout from a medical provider
Remind your patients to bring their vaccination card with them to appointments and be sure to keep it in a safe place afterwards. Don’t throw it away, and don’t post pictures online!
If you have any questions about vaccination records, please call 833-VAX-HELP.
|
|
500 DAYS OF DOMESTIC VACCINATION
This week we celebrated a huge milestone in the fight against COVID-19, 500 days since the U.S. began providing vaccinations!
We thank all of the public health professionals who have contributed to this amazing accomplishment!
|
|
NEW! TRAINING RESOURCES FOR COVID-19 VACCINATION PROVIDERS
We understand that keeping up with all of the COVID-19 vaccination information and training resources can be overwhelming and time consuming. To simplify things, DOH has put together a list of the most important resources available to help providers effectively and efficiently vaccinate Washingtonians.
This guide gives prompt access to the most current resources available. We hope you find this helpful and share with your colleagues as well!
|
|
COVID-19 VACCINES FOR PEOPLE WHO WOULD LIKE TO HAVE A BABY
COVID-19 vaccines are undergoing the most intense safety monitoring in U.S. history. Evidence continues to grow showing that COVID-19 vaccines are safe and effective before and during pregnancy, and while breastfeeding. There is also no evidence that any vaccines, including COVID-19 vaccines, cause fertility problems in women or men. COVID-19 can make you very sick, and if you become infected during pregnancy, you are at increased risk of complications that can affect your pregnancy and baby.
People who are trying to get pregnant now or might become pregnant in the future should stay up to date with their COVID-19 vaccines, including getting a COVID-19 booster when eligible.
To learn more, please visit these informative resources on the CDC website:
Stay Up to Date with Your COVID-19 Vaccines
COVID-19 Vaccines While Pregnant or Breastfeeding.
|
|
 COVID-19 VACCINES FOR PEOPLE VACCINATED OUTSIDE THE U.S.
Friendly reminder that people who have been vaccinated for COVID-19 outside of the United States need to stay up to date on their doses just like those of us who have been vaccinated domestically.
Specific recommendations for people vaccinated outside of the United States depend on whether:
- The vaccine(s) received are accepted in the United States
- The primary series was completed
- A booster dose was received
The next step is to determine if the primary series was completed. For people who were vaccinated outside of the U.S., the primary series is completed if they:
People vaccinated outside of the United States who completed the primary series should receive a booster when eligible.
People vaccinated outside of the United States who have not completed the primary series, as described above, do not have to start the primary series over. They should get one primary series dose of an mRNA COVID-19 vaccine (Pfizer-BioNTech or Moderna). If the first dose was an mRNA COVID-19 vaccine, it would be best to get the same vaccine again to complete the primary series.
|
|
INDICATE DOSAGE AMOUNT ON VACCINE CARDS
When administering a COVID-19 vaccine, it is recommended that providers indicate not only the vaccine brand, but also the dosage on the patient's vaccination card. If administering a booster dose, note "booster" as well.
Taking the time to add this extra bit of information will be very helpful during follow up appointments when providers need to understand which vaccine brands and dosages are best for the patient to receive.
To review COVID-19 standing orders, please visit the Clinical Information page on the DOH website.
|
|
OFFICE HOURS AND TRAINING SESSION
Wednesday, May 4 12:00 - 12:45pm PT
Please join us for a live presentation with the Washington State Immunization Information System (WAIIS) trainer, who will review helpful tips for COVID-19 vaccine inventory reporting. This will include an open Q & A session as well, so bring any questions you might have.
On the Agenda:
- COVID-19 Inventory Management in the WAIIS
- Receiving COVID-19 Vaccine Orders/Transfers in the WAIIS
- Inventory Decrementing with an HL7 Connection and Troubleshooting with WAIIS Reports
Join the presentation in Teams.
|
|
 NFID WEBINAR: COVID-19 UPDATE ON BOOSTER DOSES
Thursday May 5 at 12:00pm ET
Join the National Foundation for Infectious Diseases (NFID) for a webinar addressing updates on COVID-19 booster doses. Discussion topics will include current recommendations for COVID-19 vaccines and booster doses, along with strategies for health care professionals to effectively communicate COVID-19 vaccination recommendations. Speakers will also address audience-submitted questions.
NFID Medical Director William Schaffner, MD, will moderate the discussion with Peter Marks, MD, PhD, Director, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA) and Sara E. Oliver, MD, MSPH, Medical Officer, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC).
There is no fee to participate, but pre-registration is required.
|
|
|
FOR SCHOOLS AND CHILD CARE FACILITIES
-
Higher Education Recommendations 2021-2022
- This guidance reflects the CDC isolation and quarantine guidelines, including information on staying up to date with vaccinations against COVID-19.
-
Symptom Decision Tree and Contact Tracing Checklist for K-12 Schools (PDF) and Contact Tracing Guide and FAQ for K-12 Schools (PDF)
- These documents align with the current versions of K-12 School Requirements on isolation, quarantine, and the expanded Test to Stay program.
-
K-12 Schools 2021-2022 Requirements (PDF). DOH policy supports in-person learning while maximizing constrained COVID-19 testing supplies.
-
COVID-19 Vaccines: Pediatric Vaccine Toolkit for Schools (PowerPoint) This toolkit provides a variety of resources for schools, including parent handouts, backpack stuffers, and sample communication.
-
Contact Tracing Guide and FAQ for K-12 Schools This guide includes quarantine recommendations and contact tracing priority settings.
-
K-12 Schools 2021-2022 Supplemental Considerations to Mitigate COVID-19 Transmission. Information includes classroom and school closure criteria, contact tracing in high priority settings, timelines for close contact testing, and technical clarifications on antigen testing for Test to Stay programs and performing arts/sporting activities screening testing.
-
Secretary of Health’s Mask Order FAQ, to align with the secretary’s order related to athletes and coaches at large outdoor gatherings.
School and child care guidance can be found on the Department of Health web page here.
|
|
|
FOR LONG-TERM CARE FACILITIES
|
|
|
RESOURCES ON THE PFIZER COVID-19 VACCINE 12-15 AGE EXPANSION
In response to the authorized of Pfizer COVID-19 to children ages 12-15, the CDC has developed several useful tools for parents and clinicians to utilize.
Information for healthcare and vaccine providers provides basic information regarding the COVID-19 vaccine, consent and tools for communication to the community:
|
|
|
SIGN UP FOR THIS NEWSLETTER!
If you aren't already signed up for the COVID-19 Vaccine Partner Newsletter, please visit the Department of Health's email subscribers page here. Once you enter your email, on the next page expand the Immunization topic, select the COVID-19 Vaccine Partner Newsletter, and click submit.
|
|
This newsletter summarizes content from the week of April 24, 2022 and was sent out on April 29, 2022. |
|
|
|
|
